Texas A M Stem Cell Research

Professor department of pediatric surgery center for stem cell and regenerative medicine m d the university of texas medical branch galveston texas.

Texas a m stem cell research.

Texas a m university health science center is partnering with the houston company that ran into trouble with federal regulators a year after facilitating the 2011 stem cell treatment of gov. Prior to joining the texas a m university system he was director of the center for gene therapy at the tulane university health sciences center in new orleans. The stem cell institute of texas provides the latest stem cell therapies using adult stem cells to treat a wide variety of health concerns. The long term goal is to develop novel stem cell based therapies for spinal cord injury stroke and other neurological diseases.

In a new study researchers at texas a m university have combined 3d printing biomaterial engineering and stem cell biology to create superior personalized bone grafts. The comparative orthopedics and regenerative medicine laboratory at texas a m university was founded in 2012 with the specific mission to foster and expand multidisciplinary research of orthopedic disorders and regenerative therapies. The program is highly regarded nationally and internationally. When implanted at the site of repair the researchers said these grafts will not only facilitate bone cells to regrow vigorously but also serve as a sturdy platform for bone.

What do they do. From ecology and evolution to molecular cellular and developmental biology. We re still discovering some of the amazing capabilities of these cells but based on research at the texas a m health science center recently we do know that they can help repair bone and potentially. Research research in the department of biology spans the entire breadth of biology.

Our research is supported by a wide array of funding sources including nih nsf and the welch foundation. Many departmental faculty members actively participate in. The research will utilize celltex s proprietary stem cell process and will involve anti inflammatory exosomes derived from autologous mesenchymal stem cells msc according to a press release. Prockop is a pioneer in the areas of human bone marrow derived stem cells and their biology and clinical applications.